ICU · pharmacology
ICU Antihypertensive Drugs — Comprehensive
Also known as IV antihypertensives · Hypertensive emergency drugs · Labetalol · Nicardipine · Sodium nitroprusside · Clevidipine · Esmolol · Hydralazine · Phentolamine · Fenoldopam · Cyanide toxicity · Unopposed alpha stimulation
IV antihypertensives for the ICU — the nine agents every intensivist must master: LABETALOL (combined alpha+beta blocker — versatile first-line for most hypertensive emergencies; 20 mg IV bolus then 40 mg and 80 mg boluses to a 300 mg maximum in trial protocols; contraindicated in severe asthma/heart block), NICARDIPINE (dihydropyridine CCB — smooth titratable infusion 5-15 mg/h — ideal for most HTN emergencies including stroke), HYDRALAZINE (direct arteriolar vasodilator — pregnancy/pre-eclampsia favourite; 5 mg slow IV bolus repeatable; CAUTION reflex tachycardia), SODIUM NITROPRUSSIDE (arteriolar + venous NO donor — most potent — CYANIDE TOXICITY risk rises with infusion rate, cumulative dose or prolonged infusion — now largely superseded), NITROGLYCERIN (venous arteriolar NO donor — start 5 mcg/min titrating by 5 mcg/min — for ACS/acute pulmonary oedema; tachyphylaxis), CLEVIDIPINE (ultra-short DHP CCB — 1 min half-life — esterase-metabolised; VELOCITY trial: 2 mg/h start, doubled every 3 min to 32 mg/h), ESMOLOL (beta-1 selective — 500 mcg/kg load then up to 100 mcg/kg/min — aortic dissection, tachyarrhythmia), FENOLDOPAM (D1 agonist — 0.1 mcg/kg/min start — 'renal protective' claim unproven), PHENTOLAMINE (non-selective alpha-blocker — 5 mg IV bolus — pheochromocytoma crisis FIRST). Oral agents for chronic ICU BP control (ACEi/ARB, CCB, beta-blockers, diuretics, alpha-blockers). Scenario-specific rules that MUST be memorised: AORTIC DISSECTION = beta-blocker FIRST then vasodilator (prevent reflex tachycardia → propagation; target HR <60, SBP <120); HYPERTENSIVE ENCEPHALOPATHY = labetalol or nicardipine (BP down ~10% first hour, another ~15% over 2-3 h); PRE-ECLAMPSIA = hydralazine or labetalol + magnesium sulphate; PHEOCHROMOCYTOMA = phentolamine FIRST then beta-blocker (alpha before beta); COCAINE = benzodiazepines FIRST (avoid beta-blockers — unopposed alpha).
Checked against its sources on 3 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- PHEOCHROMOCYTOMA crisis: NEVER give a beta-blocker before an alpha-blocker — beta-blockade leaves catecholamine alpha-1 vasoconstriction UNOPPOSED → catastrophic worsening hypertension + pulmonary oedema. Always phentolamine (alpha-blocker) FIRST, then add beta-blocker.
- AORTIC DISSECTION: ALWAYS give a beta-blocker FIRST (target HR <60) BEFORE any vasodilator. Vasodilator alone → reflex tachycardia → increased dP/dt → propagation of the dissection flap.
- COCAINE-induced hypertension: AVOID beta-blockers (unopposed alpha → vasospasm, paradoxical hypertension). Use BENZODIAZEPINES first-line.
- SODIUM NITROPRUSSIDE: CYANIDE TOXICITY risk rises with infusion rate, cumulative dose, prolonged duration, or renal/hepatic impairment — rising lactate + metabolic acidosis + normal PaO2 (venous hyperoxia); can present late, even after the infusion is stopped. Antidote: sodium thiosulfate + hydroxocobalamin.
- Do NOT use SUBlingual nifedipine (unpredictable precipitous BP drop → stroke/MI/organ ischaemia) — withdrawn from use.
Overview & definition
References33ShowHide
- [1]Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Hypertension, 2018.PMID 29133356
- [2]van den Born BH, Lip GYH, Brguljan-Hitij J, et al. ESC Council on hypertension position document on the management of hypertensive emergencies Eur Heart J Cardiovasc Pharmacother, 2019.PMID 30165588
- [3]Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies Cochrane Database Syst Rev, 2008.PMID 18254026
- [4]Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine Circulation, 2010.PMID 20233780
- [5]Varon J. Treatment of acute severe hypertension: current and newer agents Drugs, 2008.PMID 18257607
- [6]Varon J, Marik PE Clinical review: the management of hypertensive crises Crit Care, 2003.PMID 12974970
- [7]Vigil-De Gracia P, Lasso M, Ruiz E, et al. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial Eur J Obstet Gynecol Reprod Biol, 2006.PMID 16621226
- [8]Frank Peacock W 4th, Varon J, Ebrahimi R, et al. Clevidipine for severe hypertension in patients with renal dysfunction: a VELOCITY trial analysis Blood Press Suppl, 2011.PMID 21091269
- [9]Kenyon KW Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension Ann Pharmacother, 2009.PMID 19584385
- [10]Koga M, Arihiro S, Hasegawa Y, et al. Intravenous nicardipine dosing for blood pressure lowering in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study J Stroke Cerebrovasc Dis, 2014.PMID 25314943
- [11]Narotam PK, Puri V, Roberts JM, et al. Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation J Neurosurg, 2008.PMID 19035721
- [12]Tempe DK, Mulchandani P, Tandon MS, et al. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol Indian Heart J, 1999.PMID 10624069
- [13]Krenz JR, O'Brien ME, Lee J, et al. Evaluation of esmolol for heart rate control in patients with acute aortic dissection Am J Emerg Med, 2021.PMID 32354528
- [14]Liu G, Wang D, Yang Y, et al. Efficacy and Safety of preoperative Controlling Heart Rate in Patients with Acute Type A Aortic Dissection (ESCORT): protocol for a randomised controlled trial BMJ Open, 2026.PMID 41962972
- [15]Henry K, Pelsue B, Hartman H, et al. Low versus high dosing strategies of intravenous nitroglycerin for the management of sympathetic crashing acute pulmonary edema Am J Emerg Med, 2025.PMID 40834833
- [16]Pilmer BL, Green JA, Panacek EA, et al. Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension J Clin Pharmacol, 1993.PMID 8103527
- [17]Broderick KE, Balasubramanian M, Chan A, et al. The cobalamin precursor cobinamide detoxifies nitroprusside-generated cyanide Exp Biol Med (Maywood), 2007.PMID 17526771
- [18]du Cailar J, Mathieu-Daudé JC, Deschodt J, et al. [Plasma level of the thiocyanate ion in sodium nitroprusside perfusion]. Ann Anesthesiol Fr, 1976.PMID 10791
- [19]Fog L, Pedersen OL [Hypertensive crises. 2. Treatment]. Ugeskr Laeger, 1995.PMID 8545929
- [20]Morris AA, Page RL 2nd, Baumgartner LJ, et al. Thiocyanate Accumulation in Critically Ill Patients Receiving Nitroprusside Infusions J Intensive Care Med, 2017.PMID 27435907
- [21]Udeh CI, Ting M, Arango M, et al. Delayed presentation of nitroprusside-induced cyanide toxicity Ann Thorac Surg, 2015.PMID 25841829
- [22]Elliott WJ Clinical features and management of selected hypertensive emergencies J Clin Hypertens (Greenwich), 2004.PMID 15470289
- [23]Myklejord DJ Undiagnosed pheochromocytoma: the anesthesiologist nightmare Clin Med Res, 2004.PMID 15931336
- [24]Richards JR, Garber D, Laurin EG, et al. Treatment of cocaine cardiovascular toxicity: a systematic review Clin Toxicol (Phila), 2016.PMID 26919414
- [25]Khan NN, Zurayyir EJ, Alghamdi AM, et al. Management Strategies for Hypertensive Crisis: A Systematic Review Cureus, 2024.PMID 39262522
- [26]Rose JC, Mayer SA Optimizing blood pressure in neurological emergencies Neurocrit Care, 2004.PMID 16174926
- [27]Stetson JB, Reading GP Avoidance of vascular complications associated with the use of dopamine Can Anaesth Soc J, 1977.PMID 201354
- [28]Saldana S, Breslin J 2nd, Hanify J, et al. Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Hemorrhagic Stroke Neurocrit Care, 2022.PMID 34904214
- [29]Liu C, Lv Q, Chen X, et al. Preoperative selective vs non-selective α-blockade in PPGL patients undergoing adrenalectomy Endocr Connect, 2017.PMID 28986400
- [30]Misra M, Chembale J, Kankane A Evaluation of the efficacy, safety and tolerability of intravenous enalaprilat in the treatment of grade III essential hypertension in Indian patients Indian Heart J, 2004.PMID 15129797
- [31]Borghi C, Cicero AF, Agnoletti D, et al. Pathophysiology of cough with angiotensin-converting enzyme inhibitors: How to explain within-class differences? Eur J Intern Med, 2023.PMID 36628825
- [32]Sandweiss AJ, Morrison CM, Spichler A, et al. A case report of clonidine induced syncope: a review of central actions of an old antihypertensive BMC Pharmacol Toxicol, 2018.PMID 29433586
- [33]Xiao X, Chang C Diagnosis and classification of drug-induced autoimmunity (DIA) J Autoimmun, 2014.PMID 24456934